FY2026 Earnings Forecast for IONS Issued By Leerink Partnrs
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) – Analysts at Leerink Partnrs reduced their FY2026 EPS estimates for Ionis Pharmaceuticals in a research note issued to investors on Monday, February 24th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings per share of ($3.25) for the year, down from their previous […]
